- ¥31bn
- ¥11bn
- ¥22bn
- 85
- 70
- 44
- 77
Annual income statement for Medikit Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19,893 | 19,313 | 20,131 | 21,607 | 21,851 |
Cost of Revenue | |||||
Gross Profit | 8,321 | 7,592 | 8,181 | 8,319 | 8,753 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,570 | 15,539 | 15,763 | 17,368 | 17,181 |
Operating Profit | 4,323 | 3,774 | 4,368 | 4,239 | 4,670 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,335 | 3,929 | 4,473 | 4,291 | 4,775 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,888 | 2,659 | 2,993 | 2,865 | 3,069 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,888 | 2,659 | 2,993 | 2,865 | 3,069 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,888 | 2,659 | 2,993 | 2,865 | 3,069 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 172 | 157 | 181 | 168 | 202 |
Dividends per Share | |||||
Special Dividends per Share |